JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7387 TCS OX2 29

Summary: OX2 receptor antagonist

Soluble in DMSO
B7658 TC-SP 14

Summary: agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1)

<22.52 mg/mL
A4009 CEP-18770
1 Citation

Summary: Proteasome inhibitor

insoluble in H2O; ≥16.75 mg/mL
A4136 TG101348 (SAR302503)
2 Citation

Target: FLT3|JAK|c-RET

Summary: JAK-2 inhibitor,potent and selective

≥26.23 mg/mL
A4068 SNX-2112
1 Citation

Summary: Hsp90 inhibitor,ATP-competitve,potent and selective

≥23.05 mg/mL
A4074 S/GSK1349572

Summary: HIV integrase inhibitor, novel and potent

≥41.9 mg/mL
A4163 UPF 1069

Target: PARP

Summary: Selective PARP2 inhibitor

insoluble in H2O; ≥12.7 mg/mL
A4031 Telaprevir (VX-950)
1 Citation

Target: HCV NS3-4A protease

Summary: HCV NS3-4A protease inhibitor

≥32.95 mg/mL
A4095 Pracinostat (SB939)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4119 AMG-900

Summary: Aurora kinase inhibitor

≥25.2 mg/mL